The average length of stay for malignant neoplasm of skin in Italy is forecasted to stabilize at 3.3 days per year from 2024 to 2026, with a slight decrease to 3.2 days anticipated in 2027 and 2028. In 2023, this figure stood at 3.3 days. The year-on-year variation between 2023 and 2024 shows zero change, equating to a stable trend over two years. Over the forecasted period (2024-2028), the compound annual growth rate is negative, indicating a slight decrease in length of stay.

Future trends to watch for include:

Medical advancements and technological innovations that might reduce hospital stays for skin cancer treatment.
Policy changes in healthcare that could impact hospitalization practices.
The evolution of outpatient treatments and their effect on hospital stay metrics.